Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105111208B enables efficient asymmetric hydrogenation. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112239456B details a safe Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and simplified manufacturing.
Patent CN114195726B reveals efficient CuCl catalyzed route. Reduces costs and simplifies supply chain for pharmaceutical intermediates significantly.
Patent CN113307778A details a novel Mo/Cu co-catalyzed synthesis for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.
Patent CN106567104B reveals a green electrochemical route for 1,1'-diindolylmethane derivatives, offering cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN116813544B reveals metal-free heating method for quinoline. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.
Novel Mo/Cu co-catalyzed method for 3-CF3-1,2,4-triazoles. High efficiency, mild conditions, scalable process for API intermediates.
Patent CN105732619B details a ruthenium-catalyzed one-step synthesis route offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN113735778B reveals efficient Ag2O-catalyzed synthesis. Delivers high-purity intermediates with reduced costs and scalable supply chain reliability.
Patent CN116589426B details a novel iridium-catalyzed asymmetric [4+2]-cycloaddition for high-purity chiral 1,3-benzoxazine intermediates, offering mild conditions and supply chain reliability.
Novel patent CN114262293B offers high-purity 2-amino-3-bromopyridine via protected route. Ensures cost reduction and supply reliability for pharmaceutical manufacturing.
Patent CN111423381A reveals a mild Pd-catalyzed carbonylation route for high-purity 2-trifluoromethyl imidazoles, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Mo/Cu co-catalyzed method for trifluoromethyl triazoles offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Novel aqueous synthesis for 5-I-1,2,3-triazoles offers high efficiency and cost reduction. Reliable pharmaceutical intermediate supplier for scalable production.
Novel Pd-catalyzed carbonylation method for indole and benzoxazine compounds. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN113735826B reveals a novel Pd-catalyzed carbonylation route for high-purity quinolone intermediates, offering substantial cost reduction and supply chain reliability.
Novel copper-catalyzed route for indolo[3,2-c]quinoline intermediates offers cost-effective, scalable production for antimalarial and anticancer drug development.
Novel metal-free synthesis for trifluoromethyl pyrazoles. Reduces cost and lead time for pharmaceutical intermediate manufacturing with high purity.
Patent CN112079808A reveals a room-temperature route to benzopyrans using binaphthol phosphate. Offers high yield and scalability for API intermediates.
Patent CN116640146B details a novel Pd-catalyzed one-pot synthesis for trifluoromethyl chromone quinolines, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.